These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3469179)

  • 1. Enoxacin in lower respiratory tract infections.
    Wijnands WJ; van Griethuysen AJ; Vree TB; Van Klingeren B; van Herwaarden CL
    J Antimicrob Chemother; 1986 Dec; 18(6):719-27. PubMed ID: 3469179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of the 4-quinolone enoxacin on plasma theophylline concentrations.
    Wijnands WJ; Vree TB; Van Herwaarden CL
    Pharm Weekbl Sci; 1986 Feb; 8(1):42-5. PubMed ID: 3457357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quinolone/ureidopenicillin cross-resistance.
    Piddock LJ; Wijnands WJ; Wise R
    Lancet; 1987 Oct; 2(8564):907. PubMed ID: 2889094
    [No Abstract]   [Full Text] [Related]  

  • 4. Enoxacin in the treatment of lower respiratory tract infections.
    Philip-Joet F; Nourrit J; Frances Y; Arnaud A
    J Antimicrob Chemother; 1988 Feb; 21 Suppl B():125-9. PubMed ID: 3258863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An open study of the safety and efficacy of enoxacin in complicated urinary tract infections.
    Foot M; Williams G; Want S; Roe M; Quaghebeur G; Bates S
    J Antimicrob Chemother; 1988 Feb; 21 Suppl B():97-103. PubMed ID: 3129393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enoxacin in acute exacerbations of chronic bronchitis: a comparison with amoxycillin.
    Prigogine T; Glupczynski Y; Carpiaux JP; Blogie M; Yourassowsky E; Schmerber JS
    J Antimicrob Chemother; 1988 Feb; 21 Suppl B():131-6. PubMed ID: 3129390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enoxacin in the treatment of bronchopulmonary infections.
    Joet FP; Nourrit J; Frances Y; Arnaud A
    Eur J Clin Microbiol; 1985 Oct; 4(5):512-3. PubMed ID: 3864640
    [No Abstract]   [Full Text] [Related]  

  • 8. Enoxacin: in-vitro and animal evaluation as a parenteral and oral agent against hospital bacterial isolates.
    Heifetz CL; Bien PA; Cohen MA; Dombrowski ME; Griffin TJ; Malta TE; Sesnie JC; Shapiro MA; Wold SA
    J Antimicrob Chemother; 1988 Feb; 21 Suppl B():29-42. PubMed ID: 3129392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enoxacin raises plasma theophylline concentrations.
    Wijnands WJ; van Herwaarden CL; Vree TB
    Lancet; 1984 Jul; 2(8394):108-9. PubMed ID: 6145999
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparative clinical study of enoxacin (AT-2266, ENX) and cefaclor (CCL) in chronic respiratory tract infections by a double-blind method].
    Hara K; Saito A; Izumikawa K; Yamaguchi K; Suzuyama Y; Shigeno Y; Watanabe K; Komori M; Yamashita K; Miyazaki Y
    Kansenshogaku Zasshi; 1984 Oct; 58(10):1046-72. PubMed ID: 6442319
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of experimental Pseudomonas corneal ulcers with enoxacin, a quinolone antibiotic.
    Sugar A; Cohen MA; Bien PA; Griffin TJ; Heifetz CL; Mehta S
    Arch Ophthalmol; 1986 Aug; 104(8):1230-2. PubMed ID: 3461752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Long-term treatment and clinical evaluation of enoxacin in complicated urinary tract infections].
    Washida H; Sakagami H; Iwase Y; Sasaki S
    Hinyokika Kiyo; 1987 Sep; 33(9):1508-12. PubMed ID: 3481218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enoxacin pharmacokinetics and efficacy in CF-1 mice.
    Chartrand SA; Scribner RK; Marks MI; Dice J
    J Antimicrob Chemother; 1987 Feb; 19(2):221-4. PubMed ID: 3553134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of enoxacin and its penetration into bronchial secretions and lung tissue.
    Wijnands WJ; Vree TB; Baars AM; van Herwaarden CL
    J Antimicrob Chemother; 1988 Feb; 21 Suppl B():67-77. PubMed ID: 3162904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral enoxacin used to cure spinal osteomyelitis due to aminoglycoside-resistant Pseudomonas aeruginosa.
    Bailey RR; Newman E
    N Z Med J; 1985 Jun; 98(781):508. PubMed ID: 3859782
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum and sputum concentrations of enoxacin after single oral dosing in a clinical and bacteriological study.
    Davies BI; Maesen FP; Teengs JP
    J Antimicrob Chemother; 1984 Sep; 14 Suppl C():83-9. PubMed ID: 6594325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of azlocillin in the treatment of Pseudomonas bronchopulmonary infections].
    Arnaud A; Gevaudan MJ; Saadjian M; Dugue P; Charpin J
    Presse Med; 1984 Mar; 13(13):834-7. PubMed ID: 6231607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue penetration and clinical efficacy of enoxacin in respiratory tract infections.
    Wood MJ
    Clin Pharmacokinet; 1989; 16 Suppl 1():38-45. PubMed ID: 2653694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The in-vitro activities of enoxacin and ofloxacin compared with that of ciprofloxacin.
    King A; Shannon K; Phillips I
    J Antimicrob Chemother; 1985 May; 15(5):551-8. PubMed ID: 3159712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enoxacin treatment of urinary tract infections.
    Thomas MG; Ellis-Pegler RB
    J Antimicrob Chemother; 1985 Jun; 15(6):759-63. PubMed ID: 3861605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.